TY  - GEN
AU  - Glantz,M J
AU  - LaFollette,S
AU  - Jaeckle,K A
AU  - Shapiro,W
AU  - Swinnen,L
AU  - Rozental,J R
AU  - Phuphanich,S
AU  - Rogers,L R
AU  - Gutheil,J C
AU  - Batchelor,T
AU  - Lyter,D
AU  - Chamberlain,M
AU  - Maria,B L
AU  - Schiffer,C
AU  - Bashir,R
AU  - Thomas,D
AU  - Cowens,W
AU  - Howell,S B
TI  - Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis
SN  - 0732-183X
PY  - 2000///0104
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antimetabolites, Antineoplastic
KW  - administration & dosage
KW  - Cytarabine
KW  - Delayed-Action Preparations
KW  - Female
KW  - Humans
KW  - Injections, Spinal
KW  - Lymphoma
KW  - complications
KW  - Male
KW  - Meningitis, Aseptic
KW  - drug therapy
KW  - Middle Aged
KW  - Quality of Life
KW  - Survival Analysis
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1200/JCO.1999.17.10.3110
ER  -